Lisa shared her MRI results after a three-week experimental protocol combining dry fasting and Hyperbaric Oxygen Therapy (HBOT). Out of the three weeks, she dry fasted for a total of 11 days (mostly in 2–3 day blocks followed by refeeding). While the tumour was not fully eliminated, there was a further reduction in mass compared to previous imaging (no exact measurements provided). Lymph nodes remain clear, and there has been no disease progression despite periods of dietary non-compliance. Lisa notes that extended fasting is often cited as necessary to fully trigger autophagy and cell cannibalism, but as she is very lean, she limits fasts to 4 days maximum before refeeding. She also suspects tumour resistance factors, such as MDR1 overexpression, may play a role in limiting impact. ✅ Supplements & Compounds - No specific compounds during fasting phase; paused ReDO protocol drugs to give the liver a rest - Normally uses ReDO Project repurposed drugs in her broader protocol - Will consider reintroducing supplements and off-labels after returning from travel ✅ Therapies & Strategies - Dry fasting – 11 days total over 3 weeks (in 2–3 day blocks) - HBOT – multiple sessions during the 3-week period - Refeeding phases between fasts for weight and energy recovery - Travel and sun exposure during protocol break in Florida - Considering next-stage protocol adjustments after weight and muscle recovery ✅ Lab Testing & Monitoring - MRI – confirmed tumour mass reduction (degree unspecified) and no lymph node involvement - Subjective monitoring of energy levels, muscle mass, and weight ✅ Resources & References Shared - MDR1 overexpression research in relation to tumour resistance - ReDO Project information on repurposed cancer drugs - Peer discussion on GKI, MCT oil, exogenous ketones, protein balance, and muscle rebuilding strategies ✅ Key Takeaways - Even short fasting cycles combined with HBOT may contribute to tumour reduction and stability. - Maintaining sufficient body mass is critical when fasting, especially for already lean individuals. - MDR1 overexpression may limit the effects of certain metabolic interventions, warranting tailored strategies. - Pausing certain drugs or supplements during fasting may help protect organ function but could impact protocol potency. - Ongoing experimentation, testing, and adaptation remain central to Lisa’s approach.

Lemon P shared an extensive set of links, case discussions, and practitioner references exploring Chlorine Dioxide Solution (CDS) in cancer and chronic illness. While not medical advice, the post consolidates resources from Dr. Lee Merritt, Prof. Laurent Schwartz, Dr. Manuel Aparicio-Alonso, Dr. Pierre Kory, Jim Humble, and others. Discussions included anecdotal recovery cases, practitioner protocols, historical background, and media controversies. Contributors highlighted that therapeutic CDS dosing is far lower than industrial use levels and that many public misconceptions are due to regulatory and media narratives. ✅ Supplements & Compounds Core agent: - Chlorine Dioxide Solution (CDS) – sometimes referenced as MMS (older term)Often combined with: - DMSO (dimethyl sulfoxide) for enhanced tissue penetration Reported mechanisms from shared sources: - Selective oxidation of harmful pathogens and potentially cancerous cells - Modulation of inflammation and detoxification - Antimicrobial, antiviral, antifungal, and possible antineoplastic effects ✅ Therapies & Strategies Referenced in shared links and discussions: - Dr. Lee Merritt’s Basic CDS Guide – intro protocols and dosing principles - Prof. Laurent Schwartz & Dr. Manuel Aparicio-Alonso – case on metastatic, otherwise incurable cancer using CDS (including intra-tumoral application) - Todd Callender – personal account of health recovery, including cancer improvement - Odette Rocha – using CDS + DMSO under medical supervision - Intra-tumoral and oral administration discussed in case reports - Emphasis on microdosing and precision preparation ✅ Lab Testing & Monitoring - Imaging (CT/PET) cited in case discussions to track progress - Symptom improvements such as reduced inflammation and improved energy reported anecdotally - No standardized CDS-specific biomarker testing ✅ Resources & References Shared Guides & Practitioner Material: - Dr. Lee Merritt – Basic CDS Guide (Rumble) - Dr. Manuel Aparicio-Alonso – CDS & cancer interviews - Jim Humble – MMS origin and development - Dr. Pierre Kory – History & mechanisms of CDS

Melissa was diagnosed in January 2024 with breast cancer and bone metastasis affecting the vertebrae, sacrum, iliac crest, and ribs. She began standard treatment with Kisqali (ribociclib) and Letrozole, followed by 10 sessions of radiotherapy, which greatly reduced pain and improved mobility. In May 2024, she added metabolic therapy to her approach, adjusting diet, integrating repurposed drugs, targeted supplements, and lifestyle changes. In June 2025, a PET scan revealed no hypermetabolism — indicating no visible tumors (NED). Melissa continues her protocols to maintain results. ✅ Supplements & Compounds Core agents used in her integrative approach: - Fenbendazole (Joe Tippens protocol) - CBD oil - Metformin – 1700 mg/day (split into 2 doses) - Dapagliflozin – 10 mg/day - Intravenous Vitamin C – up to 0.25 g/kg per session (titrated to tolerance) - Green tea infusion – daily - Turmeric – homegrown, daily useDietary approach: - Ketogenic diet targeting GKI of 2 (modified over time to ~3–3.5 for energy balance) - Low carb (10–30g/day) from vegetables: broccoli, mushrooms, spinach, onion, garlic - Protein: 1–1.5 g/kg body weight - Fat: ~4x protein intake - Whole foods; avoids processed or “barcode” foods ✅ Therapies & Strategies - Hyperbaric Oxygen Therapy (HBOT) – 20 sessions - Radiotherapy – 10 sessions (initial pain relief and mobility restoration) - Keto metabolic strategy – sustained long-term dietary adherence - Sunlight exposure – daily in tropical climate - Gradual protocol adjustment – modified macros to prevent excess weight loss - Considered but did not use: DON, CDA, 2DG (due to existing progress) ✅ Lab Testing & Monitoring - PET scan – confirmed NED in June 2025 - No detailed tumor marker data shared, but progression tracked via imaging - Self-monitoring of GKI for metabolic tracking ✅ Resources & References Shared - Joe Tippens Protocol (fenbendazole + CBD) - Dr. Beckman’s “barcode food” concept - GKI tracking resources for ketogenic therapy - Community encouragement and peer support throughout journey

Lisa Drake shared an impressively structured and deeply honest update on her 7-week experimental protocol, reporting further tumour mass reduction but not yet full remission. While initial tumour volume was measured at 2900mm³, recent scans provided only partial dimensions or vague terms like “stable” or “slightly reduced,” making accurate tracking difficult. Lisa now estimates the remaining tumour is between 0.8–1.2cm. Her protocol blended repurposed drugs, targeted supplements, intense fasting, metabolic strategies, and emotional healing. Despite occasional lapses, Lisa’s progress, resilience, and self-awareness drew wide admiration from the community. ✅ Key Protocol Components Shared Cycle structure: - 2 weeks on: Full drug + supplement protocol - 1 week off: Alternate days of dry fasting and keto - Repeat - Final off week: 4 days dry fast (no food/water/showering) + 3 days water-only fast Morning: - Matcha + dandelion + soursop tea - Liquid Kurk (bioavailable curcumin – 20% Onconomics sensitivity) - Capecitabine (2x 500mg – 81%) - Frankincense Carterii (3x 500mg – 25%) - Genistein (3x 125mg – 25%) - Quercetin (3x 500mg – 30%) - Agaricus blazei (3x) - Sodium Phenylbutyrate (4x 500mg – glutamine antagonist) Lunch (keto/carnivore): - Fenbendazole - Propranolol - Cimetidine - Loratadine - Dipyridamole - Metformin - Naltrexone - Celebrex - Sodium Phenylbutyrate Dinner: - Repeat morning/afternoon stack - Capecitabine taken only when protein intake is high ✅ Scientific & Philosophical Insights - Imaging inconsistencies raised questions about how to accurately measure tumour change over time. - Use of the Onconomics test to personalize supplement selection shows the value of precision-guided therapy. - Acknowledged that 7 weeks may not have been enough — 12 weeks is a more realistic window for response. - Lisa is considering shifting from attack mode (blocking pathways) to a deeper focus on gut healing and system balance, reflecting a philosophical evolution in her healing journey. - Deep insights into how gut health, trauma history, and mental health can act as barriers to progress — especially with a 20-year history of bulimia and occasional lapses.

Welcome to the Vault — your free hub for structured knowledge and clear learning. The Vault is where anyone can start understanding metabolic therapy with clarity, structure, and confidence. It’s a public learning space — designed to remove confusion, save time, and give you access to some of the deepest, most practical knowledge distilled from years of research, lived experience, and expert discussion. ⚠️ Disclaimer: This community and its content are for educational purposes only and are not a substitute for medical advice. Always consult your healthcare provider before making health decisions. This isn’t a random feed of posts — it’s a curated collection built to guide you step-by-step through the fundamentals that matter most. We believe in open access to life-saving knowledge. That’s why the Vault is free — and always will be. If this space brings you value, your continued support helps us invest in: - Better tools - Better content - A growing team - More Warriors reached, helped, and supported Each post is reviewed and structured for clarity — so you can learn fast and build a solid foundation before diving deeper inside Cancer Warriors, our private hub for advanced cases, real-world protocols, and deeper research collaboration. How to get the most from this space: - Start by exploring the Classroom, your free resource library - Read through the foundational posts on compounds, protocols, and therapies - When you’re ready for deeper integration, join Cancer Warriors to unlock the full library of advanced discussions, private research threads, and member case studies The Vault is your entry point into the metabolic therapy world — clear, organized, and freely available for anyone who’s ready to learn. 🔹What the Categories Mean We’ve created clear content categories for posts so you can quickly find what you need: 💊 Compounds & Therapies 🔬 Protocols & Case Studies 🧪 Testing & Metrics 🧠 Mindset & Challenges 📚 Research & Education 🛠️ Resources & Tools